ID:AF9_HUMAN DESCRIPTION: RecName: Full=Protein AF-9; AltName: Full=ALL1-fused gene from chromosome 9 protein; AltName: Full=Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein; AltName: Full=YEATS domain-containing protein 3; SUBUNIT: Interacts with BCOR. Interacts with CBX8. INTERACTION: Q9UHB7:AFF4; NbExp=4; IntAct=EBI-716132, EBI-395282; SUBCELLULAR LOCATION: Nucleus (By similarity). DISEASE: Note=A chromosomal aberration involving MLLT3 is associated with acute leukemias. Translocation t(9;11)(p22;q23) with MLL/HRX. The result is a rogue activator protein. SIMILARITY: Contains 1 YEATS domain. WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and Haematology; URL="http://atlasgeneticsoncology.org/Genes/AF9.html";
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
ModBase Predicted Comparative 3D Structure on P42568
Front
Top
Side
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
L13744 - Human AF-9 mRNA, complete cds. BX649194 - Homo sapiens mRNA; cDNA DKFZp686D09204 (from clone DKFZp686D09204). AK301474 - Homo sapiens cDNA FLJ53222 complete cds, highly similar to Protein AF-9. BC036089 - Homo sapiens myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3, mRNA (cDNA clone MGC:33789 IMAGE:5298142), complete cds. AK225957 - Homo sapiens mRNA for myeloid/lymphoid or mixed-lineage leukemia variant, clone: FCC114E07. AK297587 - Homo sapiens cDNA FLJ58676 complete cds, highly similar to Protein AF-9. AK312914 - Homo sapiens cDNA, FLJ93363, highly similar to Homo sapiens myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 (MLLT3), mRNA. JF432808 - Synthetic construct Homo sapiens clone IMAGE:100074126 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 (MLLT3) gene, encodes complete protein. KJ897192 - Synthetic construct Homo sapiens clone ccsbBroadEn_06586 MLLT3 gene, encodes complete protein. KU178189 - Homo sapiens myeloid/lymphoid or mixed-lineage leukemia; translocated to 3 isoform 1 (MLLT3) mRNA, partial cds. KU178190 - Homo sapiens myeloid/lymphoid or mixed-lineage leukemia; translocated to 3 isoform 3 (MLLT3) mRNA, complete cds, alternatively spliced. AB463323 - Synthetic construct DNA, clone: pF1KB8734, Homo sapiens MLLT3 gene for trithorax homolog, without stop codon, in Flexi system. BC030550 - Homo sapiens myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3, mRNA (cDNA clone IMAGE:5212069), containing frame-shift errors. CU690292 - Synthetic construct Homo sapiens gateway clone IMAGE:100019887 5' read MLLT3 mRNA. JD565885 - Sequence 546909 from Patent EP1572962. JD510796 - Sequence 491820 from Patent EP1572962. JD320417 - Sequence 301441 from Patent EP1572962. JD508203 - Sequence 489227 from Patent EP1572962. JD288797 - Sequence 269821 from Patent EP1572962. JD272218 - Sequence 253242 from Patent EP1572962. D16688 - Homo sapiens mRNA for LTG9/MLLT3 protein, partial cds. JD510234 - Sequence 491258 from Patent EP1572962. JD090626 - Sequence 71650 from Patent EP1572962. JD047050 - Sequence 28074 from Patent EP1572962. JD459893 - Sequence 440917 from Patent EP1572962. JD069610 - Sequence 50634 from Patent EP1572962. JD267082 - Sequence 248106 from Patent EP1572962. JD502712 - Sequence 483736 from Patent EP1572962. JD262571 - Sequence 243595 from Patent EP1572962. JD322738 - Sequence 303762 from Patent EP1572962. EF406122 - Homo sapiens MLL/AF9 translocation breakpoint junction sequence. JD371454 - Sequence 352478 from Patent EP1572962. MN238625 - Homo sapiens isolate 5989 KMT2A/MLLT3 fusion protein (KMT2A/MLLT3 fusion) mRNA, partial cds. AK128222 - Homo sapiens cDNA FLJ46355 fis, clone TESTI4049110. JD068375 - Sequence 49399 from Patent EP1572962. JD478328 - Sequence 459352 from Patent EP1572962. JD127196 - Sequence 108220 from Patent EP1572962. JD520328 - Sequence 501352 from Patent EP1572962. JD314278 - Sequence 295302 from Patent EP1572962.
Biochemical and Signaling Pathways
Reactome (by CSHL, EBI, and GO)
Protein P42568 (Reactome details) participates in the following event(s):
R-HSA-112381 Hyperphosphorylation (Ser2) of RNA Pol II CTD by P-TEFb complex R-HSA-113429 Elongating transcript encounters a lesion in the template R-HSA-112379 Recruitment of elongation factors to form elongation complex R-HSA-113411 2-4 nt.backtracking of Pol II complex on the template leading to elongation pausing R-HSA-113412 Pol II elongation complex moves on the template as transcript elongates R-HSA-113414 7-14 nt. Backtracking of Pol II complex on the template leading to elongation arrest R-HSA-112385 Addition of nucleotides leads to transcript elongation R-HSA-112392 Resumption of elongation after recovery from pausing R-HSA-113413 TFIIS-mediated recovery of elongation from arrest R-HSA-112395 Abortive termination of elongation after arrest R-HSA-112396 Separation of elongating transcript from template R-HSA-112382 Formation of RNA Pol II elongation complex R-HSA-674695 RNA Polymerase II Pre-transcription Events R-HSA-75955 RNA Polymerase II Transcription Elongation R-HSA-73857 RNA Polymerase II Transcription R-HSA-74160 Gene expression (Transcription)